Table 3:
Any cancer | Kaposi sarcoma | Cervical cancer | Non-Hodgkin lymphoma |
Hodgkin lymphoma |
Leukaemia | Free of cancer | |
---|---|---|---|---|---|---|---|
N=867 | N=429 | N=45 | N=107 | N=48 | N=32 | N=781,587 | |
Age | |||||||
15-19 years | 231 (26.6) | 108 (25.2) | 13 (28.9) | 25 (23.4) | 15 (31.2) | 9 (28.1) | 175,788 (22.5) |
20-24 years | 636 (73.4) | 321 (74.8) | 32 (71.1) | 82 (76.6) | 33 (68.8) | 23 (71.9) | 605,799 (77.5) |
Sex | |||||||
Female | 700 (80.7) | 347 (80.9) | 45 (100.0) | 78 (72.9) | 32 (66.7) | 20 (62.5) | 697,366 (89.2) |
Male | 167 (19.3) | 82 (19.1) | 0 | 29 (27.1) | 16 (33.3) | 12 (37.5) | 84,221 (10.8) |
Calendar period | |||||||
2004 - 2007 | 282 (32.5) | 152 (35.4) | 13 (28.9) | 32 (29.9) | 18 (37.5) | 11 (34.4) | 167,932 (21.5) |
2008 - 2011 | 423 (48.8) | 206 (48.0) | 27 (60.0) | 49 (45.8) | 20 (41.7) | 17 (53.1) | 396,989 (50.8) |
2012 - 2014 | 162 (18.7) | 71 (16.6) | 5 (11.1) | 26 (24.3) | 10 (20.8) | 4 (12.5) | 216,666 (27.7) |
Median CD4 cell count [IQR] [cells/μL] | 248 [121, 399] | 207 [84, 350] | 261 [168, 361] | 240 [139, 345] | 267 [147, 447] | 385 [208, 806] | 357 [224, 520] |
CD4 cell count [cells/μL] | |||||||
<200 | 293 (33.8) | 179 (41.7) | 15 (33.3) | 37 (34.6) | 15 (31.2) | 6 (18.8) | 147,652 (18.9) |
200-499 | 338 (39.0) | 158 (36.8) | 19 (42.2) | 42 (39.3) | 17 (35.4) | 11 (34.4) | 364,579 (46.6) |
≥500 | 127 (14.6) | 42 (9.8) | 5 (11.1) | 14 (13.1) | 10 (20.8) | 11 (34.4) | 194,531 (24.9) |
Missing | 109 (12.6) | 50 (11.7) | 6 (13.3) | 14 (13.1) | 6 (12.5) | 4 (12.5) | 74,825 (9.6) |
HIV RNA viral load [copies/ml] | |||||||
<1,000 | 44 (5.1) | 15 (3.5) | 3 (6.7) | 8 (7.5) | 3 (6.2) | 3 (9.4) | 40,988 (5.2) |
≥1,000 | 76 (8.8) | 47 (11.0) | 3 (6.7) | 11 (10.3) | 3 (6.2) | 2 (6.2) | 44,753 (5.7) |
Missing | 747 (86.2) | 367 (85.5) | 39 (86.7) | 88 (82.2) | 42 (87.5) | 27 (84.4) | 695,846 (89.0) |
Results are presented as counts and percentages if not otherwise stated.